67 Anti-hepatitis B specific β-L-2′-deoxynucleosides: [formula omitted]1, G Gosselin 2, RF Schinazi 3, and J-L Imbach 2, and J-P Sommadossi 4. 1Novirio Pharmaceuticals; USA; 2Univ. de Montpellier II, France 3Emory Univ. and VA Med. Center, Decatur, GA, USA; 4University of Alabama at Birmingham, USA

Zdroj: In Antiviral Research 2000 46(1):A55-A55
Databáze: ScienceDirect